MoneyWorks4Me

The June 2023 quarter revenue stood at Rs. 5916.30 millions, up 7.33% as compared to Rs. 5512.00 millions during the corresponding quarter last year.Profit for the quarter ended June 2023 rises by 50.06% to Rs. 395.40  millions from Rs. 263.50 millions.Operating profit for the quarter ended June 2023 rose to 725.60 millions as compared to 549.70 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 5916.30 5512.00 7.33 5916.30 5512.00 7.33 24979.70 22511.70 10.96
Other Income 6.50 2.40 170.83 6.50 2.40 170.83 22.30 47.80 -53.35
PBIDT 725.60 549.70 32.00 725.60 549.70 32.00 2846.30 3229.50 -11.87
Interest 77.70 67.90 14.43 77.70 67.90 14.43 325.30 200.60 62.16
PBDT 647.90 481.80 34.47 647.90 481.80 34.47 2521.00 3028.90 -16.77
Depreciation 117.50 118.30 -0.68 117.50 118.30 -0.68 472.90 473.90 -0.21
PBT 530.40 363.50 45.91 530.40 363.50 45.91 2048.10 2555.00 -19.84
TAX 135.00 100.00 35.00 135.00 100.00 35.00 520.00 605.00 -14.05
Deferred Tax 7.50 10.00 -25.00 7.50 10.00 -25.00 -12.50 -50.00 -75.00
PAT 395.40 263.50 50.06 395.40 263.50 50.06 1528.10 1950.00 -21.64
Equity 926.00 926.00 0.00 926.00 926.00 0.00 926.00 926.00 0.00
PBIDTM(%) 12.26 9.97 22.98 12.26 9.97 22.98 11.39 14.35 -20.57
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..